Research & IP · United States

Intellia Therapeutics

Pioneer of in vivo CRISPR editing delivered by lipid nanoparticles, co-founded by Jennifer Doudna.

Headquarters
Cambridge, Massachusetts, United States · North America
Value chain
Research & IP(Research & design)
What that means
Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
Founded
2014
Ownership
Listed
Listing
Nasdaq:NTLA on Google Finance
Website
intelliatx.com
Relevance
High at its strongest, in Synthetic Biology & Genetic Engineering

In 1 capability

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. Biotechnology & Health Technologies · Research · listed #8 of 50

    Pioneer of in vivo CRISPR editing delivered by lipid nanoparticles, co-founded by Jennifer Doudna.

    Relevance: Pioneer of in vivo CRISPR editing

    Source · en.wikipedia.org